Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Insights
Menu
Enjoy your FREE PREVIEW which shows only 2022 data and 25 documents. Contact Patent Forecast for full access.        

Z-ARCHIVE-Cannabis

Search All Applications in Z-ARCHIVE-Cannabis


Application US20200330339


Published 2020-10-22

Oral Care Composition Comprising Cannabinoids

This application discloses oral care compositions comprising cannabinoids, preferably cannabidiol and/or cannabigerol. The oral care composition disclosed in this application may be a tooth paste, a tooth powder, or a mouthwash solution. The oral care composition may be used to treat oral infectious disease, including periimplantitis, periodontitis, oral mucositis, and dental pain.



Much More than Average Length Specification


View the Patent Matrix® Diagram to Explore the Claim Relationships

USPTO Full Text Publication >

1 Independent Claim

  • 1. A cannabinoid toothpaste composition comprising: (a) at least one abrasive agent selected from the group consisting of abrasive silica, hydrated alumina, water-insoluble sodium metaphosphate, tricalcium phosphate, calcium phosphate dihydrate, anhydrous dicalcium phosphate, calcium pyrophosphate, calcium carbonate, sodium bicarbonate, and aluminum silicate; (b) at least one binder selected from the group consisting of guar gum, xanthan gum, sodium alginate, karaya gum, bentonite, carrageenan, blanose cellulose gum, and methylcellulose; (c) at least one humectant selected from the group consisting of sorbitol solution, glycerin solution, and propylene glycol; (d) at least one fluoridating agent; (e) at least one surfactant selected from the group consisting of sodium lauryl sulfate, sodium lauryl sulfoacetate, dioctyl sodium sulfosuccinate, sulfolaurate, sodium lauryl sarcosinate, sodium stearyl fumarate, and sodium stearyl lactate; (f) water; (g) a thickener; (h) lactoferrin; and (i) one or more cannabinoids, wherein the one or more cannabinoids include cannabidiol and/or cannabigerol; wherein the one or more cannabinoids is present in an amount of 0.1 to 0.5 weight percent, and wherein lactoferrin is present in an amount of 0.1 to 0.5 weigh percent.